Exploring an Industrial Manufacturing Process of a Drug Containing Tenofovir

• Published in: Journal of young pharmacists Vol. 16; no. 2; p. 280
• Main Authors: María de los Ángeles Peña, Torrado Guillermo, Torres, Norma Sofía, Peña-Fernández, Antonio, Martínez-Alonso Borja, Gallego Bárbara
• Format: Journal Article
• Language: English
• Published: Bangalore InPharm 01.04.2024
• Subjects: Acquired immune deficiency syndrome; AIDS; Antiretroviral drugs; Bioavailability; Chronic illnesses; Drug dosages; Hepatitis B; HIV; Human immunodeficiency virus; Immune system; Infections; Inflammatory diseases; Liver cancer; Manufacturing; Oral administration; Pandemics; Patient compliance; Pharmaceutical industry; Viral infections; Viruses

BackgroundTenofovir is an antiretroviral drug, a reverse transcriptase inhibitor formulated as tenofovir disoproxil in its saline form, which acts as a prodrug of tenofovir. Its clinical use is indicated in the treatment of Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV). In this work...